Nuzenio

Gossamer

Gossamer news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Gossamer Bio Stock Plummeted 82% Today — What’s Behind The Crash? - StocktwitsStocktwits · Fri, 07 Aug 2026 08:15:03 GMTGOSS News | GOSSAMER BIO INC (NASDAQ:GOSS) - ChartMillChartMill · Sat, 01 Aug 2026 02:28:51 GMTGossamer Bio (GOSS) Could Be 96% Undervalued After Its Seralutinib NDA Update - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMTWhy Gossamer Bio (GOSS) Is Up 42.9% After FDA Clears Path For Seralutinib NDA Submission - simplywall.stsimplywall.st · Thu, 30 Jul 2026 10:26:26 GMTUpdate: Gossamer Bio Extends Gains Pre-Bell Following New Drug Application Filing Plans for Pulmonary Arterial Hypertension Treatment - MoomooMoomoo · Tue, 28 Jul 2026 09:13:31 GMTChiesi retreats from Gossamer PAH programme after Phase 3 miss - European Biotechnology MagazineEuropean Biotechnology Magazine · Tue, 28 Jul 2026 07:00:00 GMTGossamer Bio Plans September 2026 Seralutinib NDA After FDA Meeting - Quiver QuantitativeQuiver Quantitative · Mon, 27 Jul 2026 20:57:00 GMTGossamer Reacquires Global Seralutinib Rights From Chiesi, Receives $5 Million - TradingViewTradingView · Mon, 27 Jul 2026 20:03:04 GMT

Timeline

Fri, 07 Aug 2026 08:15:03 GMTGossamer Bio Stock Plummeted 82% Today — What’s Behind The Crash? - Stocktwits
Sat, 01 Aug 2026 02:28:51 GMTGOSS News | GOSSAMER BIO INC (NASDAQ:GOSS) - ChartMill
Fri, 31 Jul 2026 07:00:00 GMTGossamer Bio (GOSS) Could Be 96% Undervalued After Its Seralutinib NDA Update - Yahoo Finance
Thu, 30 Jul 2026 10:26:26 GMTWhy Gossamer Bio (GOSS) Is Up 42.9% After FDA Clears Path For Seralutinib NDA Submission - simplywall.st
Tue, 28 Jul 2026 09:13:31 GMTUpdate: Gossamer Bio Extends Gains Pre-Bell Following New Drug Application Filing Plans for Pulmonary Arterial Hypertension Treatment - Moomoo
Tue, 28 Jul 2026 07:00:00 GMTChiesi retreats from Gossamer PAH programme after Phase 3 miss - European Biotechnology Magazine

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Gossamer.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.